MX2009012349A - Compuestos de ((fenil)imidazolil)metilheteroarilo. - Google Patents

Compuestos de ((fenil)imidazolil)metilheteroarilo.

Info

Publication number
MX2009012349A
MX2009012349A MX2009012349A MX2009012349A MX2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A MX 2009012349 A MX2009012349 A MX 2009012349A
Authority
MX
Mexico
Prior art keywords
methylheteroaryl
imidazolyl
phenyl
compounds
disclosed
Prior art date
Application number
MX2009012349A
Other languages
English (en)
Inventor
Ken Chow
Michael E Garst
Phong X Nguyen
Todd M Heidelbaugh
Santosh C Sinha
Smita S Bhat
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2009012349A publication Critical patent/MX2009012349A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe en la presente un compuesto de la fórmula en donde A y B se describen en la presente. También se describen métodos terapéuticos, composiciones y medicamentos relacionados con el mismo.
MX2009012349A 2007-05-14 2008-05-13 Compuestos de ((fenil)imidazolil)metilheteroarilo. MX2009012349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91783307P 2007-05-14 2007-05-14
PCT/US2008/063489 WO2008141312A1 (en) 2007-05-14 2008-05-13 ((phenyl)imidazolyl)methylheteroaryl compounds

Publications (1)

Publication Number Publication Date
MX2009012349A true MX2009012349A (es) 2009-12-01

Family

ID=39683865

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012349A MX2009012349A (es) 2007-05-14 2008-05-13 Compuestos de ((fenil)imidazolil)metilheteroarilo.

Country Status (16)

Country Link
US (1) US20100273814A1 (es)
EP (1) EP2155715B1 (es)
JP (1) JP5323059B2 (es)
KR (1) KR20100031502A (es)
CN (1) CN101743240B (es)
AU (1) AU2008251324B2 (es)
BR (1) BRPI0811860A2 (es)
CA (1) CA2687303C (es)
DK (1) DK2155715T3 (es)
ES (1) ES2402746T3 (es)
IL (1) IL202137A0 (es)
MX (1) MX2009012349A (es)
NZ (1) NZ599554A (es)
RU (1) RU2478631C2 (es)
WO (1) WO2008141312A1 (es)
ZA (1) ZA200908088B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2712256A1 (en) * 2008-01-18 2009-07-23 Allergan, Inc. Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
EP3463359A4 (en) * 2016-06-02 2020-08-26 Purdue Pharma LP SPURENAMINE-ASSOCIATED RECEPTOR-1 AGONISTS AND PARTIAL AGONISTS FOR PAIN MANAGEMENT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931714C2 (de) * 1988-09-22 1998-04-16 Minolta Camera Kk Toner zum Entwickeln elektrostatischer, latenter Bilder, umfassend spezifizierte Imidazole
US5750720A (en) * 1996-03-28 1998-05-12 Ortho Pharmaceutical Corporation 4- (thien-3-yl)methyl!-imidazole analgesics
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
JP2008514603A (ja) * 2004-09-24 2008-05-08 アラーガン、インコーポレイテッド α２アドレナリン作動剤としての４−（ヘテロアリール−メチルおよび置換ヘテロアリール−メチル）−イミダゾール−２−チオン

Also Published As

Publication number Publication date
ZA200908088B (en) 2010-12-29
EP2155715A1 (en) 2010-02-24
NZ599554A (en) 2013-12-20
JP2010527369A (ja) 2010-08-12
CN101743240B (zh) 2013-07-17
CA2687303A1 (en) 2008-11-20
CN101743240A (zh) 2010-06-16
EP2155715B1 (en) 2013-03-13
RU2009145817A (ru) 2011-06-20
CA2687303C (en) 2015-05-05
ES2402746T3 (es) 2013-05-08
WO2008141312A1 (en) 2008-11-20
AU2008251324B2 (en) 2014-05-01
RU2478631C2 (ru) 2013-04-10
AU2008251324A1 (en) 2008-11-20
KR20100031502A (ko) 2010-03-22
IL202137A0 (en) 2010-06-16
DK2155715T3 (da) 2013-05-13
JP5323059B2 (ja) 2013-10-23
BRPI0811860A2 (pt) 2014-11-18
US20100273814A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
UA94833C2 (en) Substituted bicyclolactams
SG171617A1 (en) Therapeutic compounds
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
TN2010000102A1 (en) Novel fungicides
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
MY148703A (en) Polycyclic cinnamide derivatives
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
MX2010012390A (es) Derivados de indazoles sustituidos con fenilo o piridinilo.
IL204437A (en) History of aryl cyclic profile and their use
TN2011000291A1 (en) Purine compounds
GEP20135786B (en) Pyrrole compounds
TN2011000172A1 (en) Therapeutic antiviral peptides
TW200745084A (en) Novel compounds
MX2009012125A (es) Compuestos terapeuticos.
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
MX2009001578A (es) Lactamas terapeuticas.
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
TW200738627A (en) Trialkylsilyl-indoles
MY149400A (en) Bridged six-membered ring compounds
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
NZ611169A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
UA99840C2 (ru) Замещенные циклопентаны, которые имеют простагландиновую активность

Legal Events

Date Code Title Description
FG Grant or registration